CannaPharmaRX, Inc.
CPMD · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | -357.9% | – | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -931.7% | – | – | – |
| Net Income | -$0 | $0 | -$0 | -$0 |
| % Margin | -1,207.8% | – | – | – |
| EPS Diluted | -0.016 | 0.012 | -0.04 | -0.12 |
| % Growth | -232.8% | 129.5% | 66.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |